Genus plc (LON:GNS)
London · Delayed Price · Currency is GBP · Price in GBX 2,500.00
-5.00 (-0.20%)
Sep 3, 2025, 5:28 PM BST
Genus Market Cap
Genus has a market cap or net worth of 1.64 billion as of September 3, 2025. Its market cap has increased by 46.65% in one year.
Market Cap
1.64B
Enterprise Value
1.89B
Revenue
671.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
2,500.00
Market Cap Chart
Since January 30, 1998, Genus's market cap has increased from 31.03M to 1.64B, an increase of 5,192.63%. That is a compound annual growth rate of 15.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 1.65B | 61.62% |
| Dec 31, 2024 | 1.02B | -28.43% |
| Dec 29, 2023 | 1.42B | -27.10% |
| Dec 30, 2022 | 1.95B | -39.35% |
| Dec 31, 2021 | 3.22B | 18.11% |
| Dec 31, 2020 | 2.72B | 32.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 183.76B |
| GSK plc | 58.31B |
| Haleon | 32.30B |
| Smith & Nephew | 12.07B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.94B |
| HUTCHMED (China) | 1.87B |
| Oxford Nanopore Technologies | 1.78B |